Federal contract award
75N91020F00005
PRODUCTION OF VARIOUS STRENGTH OF IPDR CAPSULES FOR CLINICAL USE; POP: 05/08/2020 - 05/07/2021
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NIH NCI |
| NAICS | 325412 — Pharmaceutical Preparation Manufacturing |
| PSC | B504 — Chemical/Biological Studies and Analysis |
| Parent award / vehicle | HHSN261201500009I |
| Set-aside | Not reported |
| Pricing type | COST PLUS FIXED FEE |
| Obligations | $223.8K |
| Current contract value | $223.8K |
| Potential contract value / ceiling | $605.4K |
| Start date | May 8, 2020 |
| Current end date | May 7, 2022 |
| Potential end date | May 7, 2025 |
| Latest award activity | Aug 6, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 3 of 3 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Aug 6, 2026 | P00002 | $-1.3K | FY26 UDO INITIATIVE PRODUCTION OF VARIOUS STRENGTH OF IPDR CAPSULES FOR CLINICAL USE; POP: 05/08/2020 - 05/07/2021 |
| May 3, 2021 | P00001 | $115.3K | PRODUCTION OF VARIOUS STRENGTH OF IPDR CAPSULES FOR CLINICAL USE POP: 05/08/2020 - 05/07/2021 |
| May 4, 2020 | 0 | $109.8K | PRODUCTION OF VARIOUS STRENGTH OF IPDR CAPSULES FOR CLINICAL USE; POP: 05/08/2020 - 05/07/2021 |
Research next steps
- Verify whether remaining options may extend performance beyond the current end date.
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.